Literature DB >> 227784

The immunological generation of a platelet-activating factor and a platet-lytic factor in the rat.

F H Valone, D I Whitmer, W C Pickett, K F Austen, E J Goetzl.   

Abstract

Antigen challenge of the rat peritoneal cavity which had been prepared with IgGa-rich antiserum generated activities which released [14C]-serotonin from pre-labelled human platelets. After adsorption of these activities onto Amberlite XAD-8 and elution in 80% ethanol, two factors of differing polarity were resolved by chromatography on diethylaminoethyl cellulose in organic solvents. The activity eluting in the 7:1 chloroform:methanol solvent contained a platelet-lytic factor (PLF) assessed by the parallel release of lactic acid dehydrogenase and [14C]-serotonin; the cytotoxicity of this fraction was confirmed by phase-contrast microscopy examination which demonstrated fragmentation of the exposed platelets. The activity eluting in the 1:1 methanol: aqueous 1.0 M ammonium carbonate solvent was a platelet-activating factor (PAF) as defined by release of [14C]-serotonin without lactic acid dehydrogenase. Both the lytic and the activating principles were separable from slow reacting substance of anaphylaxis and polymorphonuclear leucocyte chemotactic activity, and each presented a single activity peak of differing mobility when chromatographed on silica gel H plates. Human eosinophil phospholipase D inactivated the lytic factor by more than 85% in 2 h at 37 degrees without affecting the activity of the activating factor. The release of [14C]-serotonin induced by the PAF was not affected by the absence of calcium from the medium or by elevations in the platelet concentrations of cyclic AMP or cyclic GMP that resulted from pre-incubation of platelets with prostaglandin D2 or sodium ascorbate, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227784      PMCID: PMC1457121     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  EFFECTS OF INORGANIC IONS AND OF PLASMA PROTEINS ON THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1964-03       Impact factor: 5.182

2.  Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine.

Authors:  G S Schoepflin; W Pickett; K F Austen; E J Goetzl
Journal:  J Cyclic Nucleotide Res       Date:  1977-10

3.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

4.  Immunologic release in the rat peritoneal cavity lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes.

Authors:  F H Valone; E J Goetzl
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Interrelations of platelet aggregation and secretion.

Authors:  I F Charo; R D Feinman; T C Detwiler
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

6.  The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis.

Authors:  R P Orange; R C Murphy; M L Karnovsky; K F Austen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

7.  The requirement for sensitized lymphocytes in one form of antigen-induced histamine release from rabbit platelets.

Authors:  M J Schoenbechler; J F Barbaro
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

8.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  9 in total

1.  Bronchoalveolar lavage in the cat: cytological findings.

Authors:  G M McCarthy; P J Quinn
Journal:  Can J Vet Res       Date:  1989-07       Impact factor: 1.310

Review 2.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 3.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

Review 4.  The human eosinophil: roles in host defense and tissue injury.

Authors:  P F Weller; E J Goetzl
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

5.  Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

6.  Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).

Authors:  F H Valone; E J Goetzl
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

7.  Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine.

Authors:  F H Valone; E J Goetzl
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

8.  Structural requirements for the activity of an immunologically generated lipid chemotactic factor.

Authors:  F H Valone; E J Goetzl
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

9.  Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.

Authors:  L M McManus; D J Hanahan; R N Pinckard
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.